Literature DB >> 9632079

Osteoclast-like cells in murine collagen induced arthritis.

Y Suzuki1, F Nishikaku, M Nakatuka, Y Koga.   

Abstract

OBJECTIVE: To investigate the participation of osteoclast-like bone resorbing cells in the joint destruction of murine collagen induced arthritis (CIA).
METHODS: After induction of CIA in DBA/1J mice, a histological time course study was conducted on paw sections stained for tartrate resistant acid phosphatase (TRAP), a marker of osteoclasts. Cells from arthritic paws were cultured in vitro with or without indomethacin (IM) or anti-interleukin 6 neutralizing antibody (anti-IL-6), and stained for TRAP. Levels of prostaglandin E2 (PGE2), IL-1beta, IL-6, and tumor necrosis factor-alpha in the culture supernatants were determined by ELISA. The bone resorbing ability of these cells was examined on dentine slices. In control experiments, cells of normal paws or of arthritic tibiae were cultured in the same manner.
RESULTS: TRAP positive osteoclast-like cells were detected late in the development of bone lesions at every eroded front in the pannus-bone and the pannus-subchondral bone junctions of arthritic joints. In vitro, cells of arthritic paws formed bone resorbing osteoclast-like cells spontaneously. However, the control culture failed to form these cells. PGE2 and IL-6 were detected at higher levels in arthritic culture than in control culture. Although both indomethacin and anti-IL-6 reduced osteoclast-like cell formation and indomethacin inhibited PGE2 synthesis, indomethacin failed to reduce IL-6.
CONCLUSION: These findings suggest the direct participation of osteoclast-like cells in the joint destruction of CIA, the locally enhanced activity of osteoclast-like cell differentiation in arthritic paws, and the participation of prostaglandins and prostaglandin-independent IL-6 in this differentiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632079

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  22 in total

1.  Mesenchymal stromal cells versus betamethasone can dampen disease activity in the collagen arthritis mouse model.

Authors:  E S M El-Denshary; L A Rashed; M Elhussiny
Journal:  Clin Exp Med       Date:  2013-08-30       Impact factor: 3.984

2.  Expression and function of wingless and frizzled homologs in rheumatoid arthritis.

Authors:  M Sen; K Lauterbach; H El-Gabalawy; G S Firestein; M Corr; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 3.  RANKL as a therapeutic target of rheumatoid arthritis.

Authors:  Sakae Tanaka; Yoshiya Tanaka
Journal:  J Bone Miner Metab       Date:  2020-10-18       Impact factor: 2.626

4.  TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis.

Authors:  A R Pettit; H Ji; D von Stechow; R Müller; S R Goldring; Y Choi; C Benoist; E M Gravallese
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

Review 5.  Bone destruction in arthritis.

Authors:  E M Gravallese
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

Review 6.  Pathogenesis of bone lesions in rheumatoid arthritis.

Authors:  Steven R Goldring; Ellen M Gravallese
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

Review 7.  Impact of inflammation on the osteoblast in rheumatic diseases.

Authors:  Rebecca Baum; Ellen M Gravallese
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

Review 8.  Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.

Authors:  Rebecca Baum; Ellen M Gravallese
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

9.  Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice.

Authors:  Berno Dankbar; Michelle Fennen; Daniela Brunert; Silvia Hayer; Svetlana Frank; Corinna Wehmeyer; Denise Beckmann; Peter Paruzel; Jessica Bertrand; Kurt Redlich; Christina Koers-Wunrau; Athanasios Stratis; Adelheid Korb-Pap; Thomas Pap
Journal:  Nat Med       Date:  2015-08-03       Impact factor: 53.440

10.  Selective cyclooxygenase-2 inhibitor prevents reduction of trabecular bone mass in collagen-induced arthritic mice in association with suppression of RANKL/OPG ratio and IL-6 mRNA expression in synovial tissues but not in bone marrow cells.

Authors:  Tomonori Taketa; Akinori Sakai; Shinya Tanaka; Kenichiro Nakai; Kunitaka Menuki; Hirotoshi Yamane; Kazuhiro Tanaka; Toshitaka Nakamura
Journal:  J Bone Miner Metab       Date:  2008-02-27       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.